Roche

Swiss drugmaker Roche buys US blood testing company CMI for $220 mn

02 Jul 2013

Roche inks $600 mn hormone disorders development deal with Chiasma

18 Feb 2013

Illumina reportedly agrees to Roche's $8.2-bn takeover offer

21 Dec 2012

The potential acquisition of Illumina would make Roche a market leader in gene sequencing, a procedure that helps develop personalised drugs to suit individual patients

Roche’s patent on Hepatitis C drug set aside

02 Nov 2012

The amended Patents Act allows any interested party, including patients, to challenge a patent after it was granted

Roche ends $6.7-bn hostile bid for Illumina

19 Apr 2012

The potential acquisition of Illumina would have made Roche a market leader in gene sequencing, a procedure that helps develop targeted therapies

ISS backs Illumina board; urges rejection of Roche's $6.7-bn bid

07 Apr 2012

ISS says that taking into account the valuation metrics of normal acquisitions, Roche’s offer is inadequate for Illumina whose real potential  is the vast end markets in and beyond healthcare

Letter to Roche from Illumina’s president and CEO

03 Apr 2012

Illumina rejects Roche’s $6.7-bn bid

03 Apr 2012

US-based gene sequencing company Illumina Inc yesterday rejected Swiss drugmaker Roche Holding's increased takeover offer, saying it dramatically undervalued the company

Roche increases hostile offer for Illumina to $6.7 billion

29 Mar 2012

Roche asks Illumina investors to accept its $5.7-bn bid

21 Mar 2012

Swiss drugmaker Roche told Illumina shareholders that its offer price is fair and provides value certainty and liquidity amid increasing headwinds in the gene-sequencing sector

Roche extends hostile $5.7-billion offer for Illumina

27 Feb 2012

Illumina rejects Roche's $5.7- bn hostile bid

08 Feb 2012

US-based gene sequencing leader Illumina has rejected Roche's $5.7-billion hostile takeover bid saying that the Swiss drug maker’s offer was inadequate and dramatically undervalued the company

Roche Diagnostics plans Jafza headquarters for Middle East

30 Jan 2012

Roche to buy hepatitis C drug developer Anadys for $230 million

18 Oct 2011

Roche to acquire cervical cancer detection firm MTM Laboratories

19 Jul 2011

Roche to axe 4,800 jobs in $2.1-b restructuring

17 Nov 2010

GSK sues Roche over Genentech's cancer drug patent infringement

23 Sep 2010

Roche bets $1.1 billion on Aileron Therapeutics stapled peptide

25 Aug 2010

Roche to buy cancer diagnostic firm BioImagene Inc for $100 million

24 Aug 2010

Roche buys Lonza’s Singapore unit for $360 million

02 Sep 2009

Global healthcare giant, Roche agreed to acquire the Singapore facility of Lonza, a manufacturer of pharmaceutical ingredients, for approximately $360 million

SC refuses to hear Roche's patent plea against Cipla

28 Aug 2009

Carl Icahn attempts to get nominees on Biogen board after blockbuster drug drags

07 Feb 2009

Roche confirms plans to acquire remaining 44 per cent in Genentech

21 Oct 2008

Genentech rejects Roche’s $43.7-billion takeover offer as too low

13 Aug 2008

Biotechnology giant Genentech Inc today rejected a $43.7-billion takeover bid from its majority shareholder, Roche Holding AG, as too low, while saying it would be open to a higher proposal.

Cipla to continue selling its version of Roche's lung cancer treatment drug

20 Mar 2008

View details about the software product Informachine News Trackers